Boston Scientific develops, manufactures, and markets medical devices. Q4 earnings were reported this week providing a clear picture of 2022 annual fundamentals. The fundamentals considered are presented on the chart with brief commentary.
Technical considerations:
Price bounced off of trend line going back to 2012
Ascending triangle breakout
New ATH weekly close
Positions:
Entry: 100 shares @ $48.71
Target: $67.43 by July 2025
Stop: $44.19 (~20-week SMA, below 2023 low)
R/R: 4.14
Reward: $1872
Risk: $452
Time Horizon: 12+ months
Current price (weekly close): $48.50
Risk Analysis Chart:
Main chart before distorted by publishing process:
Technical considerations:
Price bounced off of trend line going back to 2012
Ascending triangle breakout
New ATH weekly close
Positions:
Entry: 100 shares @ $48.71
Target: $67.43 by July 2025
Stop: $44.19 (~20-week SMA, below 2023 low)
R/R: 4.14
Reward: $1872
Risk: $452
Time Horizon: 12+ months
Current price (weekly close): $48.50
Risk Analysis Chart:
Main chart before distorted by publishing process:
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。